BEYOND GLYCEMIC CONTROL: ASSESSING ADHERENCE AND BARRIERS TO ANNUAL SCREENING RECOMMENDATIONS FOR DIABETIC COMPLICATIONS IN HOSPITALIZED PATIENTS AT A TERTIARY CARE HOSPITAL IN PAKISTAN.

Main Article Content

Muhammad Usman Sharif
Muhammad Hamza
Abrar Ali Shah
Syeda Amal Fatima
Hamza Ali Khan
Hina Jamshed
Saad Qadeer
Muqadas Munir
Naeem Haider Shah
Ahmad Munawar

Keywords

Diabetes mellitus, complication screening, adherence, barriers, hospitalized patients, Pakistan

Abstract

Background: Diabetes mellitus (DM) poses a rapidly growing public health challenge in Pakistan, with a high burden of preventable microvascular and macrovascular complications. International guidelines recommend annual screening for complications such as retinopathy, nephropathy, neuropathy, dyslipidemia, and cardiovascular risk, yet adherence to these recommendations remains poorly studied in hospitalized diabetic populations. This study aimed to assess adherence to guideline-recommended annual complication screening and to identify barriers and associated factors among hospitalized diabetic patients in a tertiary care hospital in Pakistan.


Methods: A hospital-based, cross-sectional study was conducted in the Department of Medicine at Ayub Teaching Hospital, Abbottabad, from September 2024 to January 2025. Four hundred adult patients with known diabetes mellitus admitted to medical wards were enrolled using consecutive sampling. Data on demographics, clinical history, recent HbA1c levels, and documentation of recommended annual screening tests were collected through structured questionnaires and record review. Adherence was categorized as full, partial, or none. Associations between adherence and patient characteristics were analyzed using Chi-square tests, t-tests/ANOVA, and logistic regression to identify independent predictors of non-adherence.


Results: The mean age of participants was 56.8 ± 11.9 years, with 54.5% males and 91.2% having type 2 DM. The mean duration of diabetes was 9.6 ± 6.1 years, and 69.2% had poor glycemic control (HbA1c > 7%). Only 91 patients (22.8%) were fully adherent, 185 (46.2%) were partially adherent, and 124 (31.0%) were non-adherent to all annual screenings. Blood pressure monitoring (92.3%) and lipid profiling (64.7%) had the highest adherence rates, whereas retinal examination (24.5%) and comprehensive foot examination (19.8%) showed the lowest. Younger age (<60 years), shorter duration of diabetes (<10 years), and good glycemic control (HbA1c ≤ 7%) were significantly associated with higher adherence (p < 0.05). Multivariate analysis identified older age (AOR 1.72, 95% CI 1.11–2.66), longer disease duration (AOR 1.48, 95% CI 1.01–2.19), and poor glycemic control (AOR 2.36, 95% CI 1.48–3.77) as independent predictors of non-adherence. Financial constraints (40.1%), lack of awareness (30.1%), and limited access to specialist services (18.1%) were the most frequently cited barriers.


Conclusion: Adherence to annual complication screening among hospitalized diabetic patients was suboptimal, with fewer than one-quarter achieving full adherence. This highlights a critical gap in preventive diabetes care. Addressing financial barriers, improving patient education, and integrating standardized screening protocols into inpatient care could enhance adherence and reduce the long-term burden of diabetes-related complications in Pakistan.

Abstract 68 | PDF Downloads 8

References

1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.
2. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: IDF; 2021.
3. Basit A, Fawwad A, Qureshi H, Shera AS. Prevalence of diabetes, pre-diabetes and associated risk factors: Second National Diabetes Survey of Pakistan (NDSP), 2016–2017. BMJ Open. 2018;8(8):e020961.
4. Meo SA, Zia I, Bukhari IA, Arain SA. Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. J Pak Med Assoc. 2016;66(12):1637–42.
5. Shera AS, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract. 2007;76(2):219–22.
6. American Diabetes Association. Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Suppl 1):S1–S264.
7. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82.
8. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.
9. Stratton IM, Adler AI, Neil HA, et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes: Prospective observational study. BMJ. 2000;321(7258):405–12.
10. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management. NG28. 2015 (updated 2022).
11. World Health Organization. Package of essential noncommunicable (PEN) disease interventions for primary health care. Geneva: WHO; 2020.
12. Ali MK, Bullard KM, Gregg EW. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med. 2013;368(17):1613–24.
13. Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Pract. 2018;137:137–48.
14. Hussain A, Ali I. Diabetes mellitus in Pakistan: A major public health concern. Arch Pharm Pract. 2016;7(1):30–33.
15. Riaz M, Basit A, Fawwad A, et al. Factors associated with non-adherence to diabetes medication in patients with type 2 diabetes. J Ayub Med Coll Abbottabad. 2014;26(3):26–9.
16. Jafar TH, Haaland BA, Rahman A, et al. Non-communicable diseases and injuries in Pakistan: Strategic priorities. Lancet. 2013;381(9885):2281–90.
17. Riaz M, Basit A, Fawwad A. The status of diabetes care in Pakistan: A review. Pak J Med Sci. 2016;32(2):483–8.
18. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–81.
19. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676–85.
20. Saeed A, Saeed H, Saleem Z, et al. Diabetes care in Pakistan: A review of current practice and future perspectives. Curr Diabetes Rev. 2019;15(6):460–8.
21. Aamir AH, Ul-Haq Z, Mahar SA, Qureshi FM, Ahmad I, Jawa A, et al. Diabetes prevalence survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open. 2019;9(2):e025300.
22. Khandekar R, Munoz B, Gilbert C. Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan. Asian J Ophthalmol. 2005;7(1):7–13.
23. Memon MS, Shaikh SA, Shaikh AR, Fahim MF, Mumtaz SN, Ahmed N. Prevalence of diabetic retinopathy in rural Pakistan: A population based cross-sectional study. BMJ Open Ophthalmol. 2022;7(1):e001032.
24. Shaikh MA, Malik R, Islam ZU, Bukhari MH, Sharif S, Alam T. Screening and prevalence study of diabetic retinopathy in Multan, district of Pakistan: a cross sectional study. Pak J Med Life Sci. 2020;3(2):85–92.
25. Khan MS, Rabnawaz R, Saeed R, Ahmad J. Financial and treatment compliance challenges among diabetic patients: a cross-sectional study from Pakistan. J Pak Med Assoc. 2024;74(7):1123–1129.
26. Shaikh SA, Shaikh AR, Memon MS. Awareness of diabetic retinopathy among diabetic patients at a tertiary care hospital of Rawalpindi, Pakistan. J Ayub Med Coll Abbottabad. 2021;33(2):273–277.
27. Shams N, Amjad S, Kamal S, Malik A, Ahmed W. Assessment of medication adherence among type 2 diabetic patients in Quetta city, Pakistan. Trop J Pharm Res. 2017;16(6):1347–1353.
28. Stark Casagrande S, Cowie CC. Health insurance coverage among people with and without diabetes in the US adult population. Diabetes Care. 2012;35(11):2243–2249.
29. Basit A, Riaz M, Fawwad A. Improving diabetes care in developing countries: the example of Pakistan. Diabetes Res Clin Pract. 2015;107(2):224–232.

Most read articles by the same author(s)